The offer is being made through Harmony Row Acquisition Co., a wholly owned GSK subsidiary, and targets all outstanding Class A and Class B shares of Nuvalent
The company emphasized that its mRNA system is built on three pillars—mRNA science, delivery science, and manufacturing processes
Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties
CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours
This makes the company among few in India to offer fully integrated, end-to-end ADC drug substance development and manufacturing, encompassing payload synthesis, linker development and manufacturing
New Centre of Excellence brings advanced robotic platforms and multidisciplinary expertise under one roof to expand access to precision-led minimally invasive surgery
With this commissioning, Shilpa Medicare joins a very small group of Indian companies capable of offering end-to-end ADC Drug Substance development and manufacturing
About 250+ women riders participate in the awareness ride where free breast screening camp were conducted
The company said the safety profile remained consistent with earlier studies and was considered manageable
Researchers emphasized that the benefit persisted well beyond the treatment period, reinforcing the clinical rationale for time-limited therapy in selected patients
Subscribe To Our Newsletter & Stay Updated
